bullish
Pre-IPO Sirnaomics Ltd. - Cautious Optimism Is Still Recommended
274 Views29 Sep 2021 09:08
This article mainly analyzed Sirnaomics in terms of the industry characteristics, the delivery platforms, the pipeline and the concerns of the Company.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- China Healthcare Weekly (Jan.13)- Tigermed, HBM, Brii, Jacobio, Dental Implant, Successful Investors15 Jan 2023
- People's Insurance (PICC) (1339.HK) - The Rally (If Any) May Not Last Despite Undervalued08 Sep 2022
- Sirnaomics (2257.HK)-Unverified Technology and Uncertainties Can Lead to Big Swings in Share Price07 Sep 2022
- WuXi AppTec (603259.CH/2359.HK) - The Smart Business Model21 Sep 2021
- CanSino Biologics (688185.CH/6185.HK) 2021/1H - Concerns on Key Products and the Outlook07 Sep 2021
- Innovent Biologics (1801.HK) - The Strength and the Concerns31 Aug 2021
x